Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.

Artificial Intelligence (“AI”) use in business has proliferated in recent years; risks arising from this therefore must be managed. Whilst the use of AI can drive significant efficiency gains for most ...

Current laboratory studies on the impact of biomaterial properties on immune responses often focus on single or limited combinations of features, providing an incomplete picture.In a recent work ...

A conversation with Professor Miraz Rahman, Head of the Department of Drug Discovery at King’s College London.